KOCAA
FATE icon

Knights of Columbus Asset Advisors’s Fate Therapeutics FATE Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,184
Closed -$120K – 380
2023
Q4 		$120K Buy
32,184
+16,092
+100% +$38K 0.01% 339
2023
Q3 		$34.1K Hold
16,092
– – ﹤0.01% 363
2023
Q2 		$76.6K Sell
16,092
-12,783
-44% -$70.5K 0.01% 351
2023
Q1 		$165K Hold
28,875
– – 0.02% 312
2022
Q4 		$291K Sell
28,875
-303
-1% -$5.69K 0.03% 278
2022
Q3 		$654K Buy
29,178
+3,533
+14% +$102K 0.07% 232
2022
Q2 		$635K Buy
25,645
+100
+0.4% +$2.76K 0.06% 239
2022
Q1 		$990K Buy
25,545
+288
+1% +$11.2K 0.08% 230
2021
Q4 		$1.48M Buy
25,257
+499
+2% +$28.3K 0.12% 218
2021
Q3 		$1.47M Buy
24,758
+20
+0.1% +$1.57K 0.13% 212
2021
Q2 		$2.15M Buy
24,738
+2,860
+13% +$230K 0.2% 174
2021
Q1 		$1.8M Sell
21,878
-288
-1% -$27.6K 0.18% 195
2020
Q4 		$2.02M Sell
22,166
-13,987
-39% -$869K 0.21% 168
2020
Q3 		$1.45M Sell
36,153
-5,254
-13% -$183K 0.18% 190
2020
Q2 		$1.42M Buy
41,407
+1,808
+5% +$53.9K 0.17% 184
2020
Q1 		$879K Sell
39,599
-25,687
-39% -$650K 0.11% 262
2019
Q4 		$1.28M Buy
+65,286
New +$1.04M 0.11% 296

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Knights of Columbus Asset Advisors's FATE Position: Q1 2024 in Review

Knights of Columbus Asset Advisors sold out of Fate Therapeutics (FATE) in Q1 2024, closing a stake of 32,184 shares — an estimated $120K sold.

Knights of Columbus Asset Advisors first reported a position in FATE in Q4 2019 and held it in 17 quarters. The position peaked at $2.15M in Q2 2021. 167 funds tracked by Wall St. Rank hold FATE as of Q1 2024.

  • Knights of Columbus Asset Advisors reported no remaining Fate Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 32,184 Fate Therapeutics shares in Q1 2024, an estimated $120K.
  • Knights of Columbus Asset Advisors first reported a position in Fate Therapeutics in Q4 2019 and held it in 17 quarters.
  • Knights of Columbus Asset Advisors's Fate Therapeutics position peaked at $2.15M in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2024, filed 10 May 2024.